Sage Capital Management, LLC

Q4 2013 13F Holdings Report, Stock Holdings

Signature - Title
Michael C. Ippolito, Cfa - CHIEF COMPLIANCE OFFICER
Location
Sarasota, FL
Holdings as of
31 Dec 2013
Value $
$93,473,000
Num holdings
37
Filing time
23 Jan 2014, 16:27:04 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included UNITED THERAPEUTICS CORP DEL, VIROPHARMA INC, ENPRO INDS INC, OMNICARE INC, and SALIX PHARMACEUTICALS INC.
Next filing
Q1 2014 - 06 May 2014
SEC
View on sec.gov
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
MICHAEL C. IPPOLITO, CFA CHIEF COMPLIANCE OFFICER Sarasota, Florida 23 Jan 2014